AlisonKConlinMD

Oncology • Portland, OR

Practicing Hematologist & Oncologist in associated with Providence Cancer Center

Join to view full profile

Dr. Conlin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Conlin's full profile

Already have an account?

Office
4805 Ne Glisan St
11th Franz
Portland, OR 97213
Phone+1 503-215-5696
Is this information wrong?

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2002 - 2005
SUNY Upstate Medical UniversityClass of 2002

Certifications & Licensure

OR State Medical License 2008 - 2025
NY State Medical License 2003 - 2009
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer Start of enrollment: 2007 Oct 12
Active, not recruiting
Phase 3
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct Start of enrollment: 2008 Dec 01
Completed
Phase 2
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Start of enrollment: 2009 Jul 01
Completed
Phase 2
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnos Start of enrollment: 2011 Jan 01
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma Start of enrollment: 2010 Mar 15
Active, not recruiting
Phase 1, Phase 2
Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy Start of enrollment: 2010 Apr 01
Completed
Phase 2
S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer Start of enrollment: 2011 Nov 01
Completed
Not Applicable
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Start of enrollment: 2011 Jan 24
Active, not recruiting
Phase 3
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Start of enrollment: 2010 Sep 15
Terminated
Phase 3
Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery Start of enrollment: 2010 Oct 15
Completed
Phase 2
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 08
Active, not recruiting
Phase 2
Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer Start of enrollment: 2010 Oct 14
Completed
Phase 1
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
Active, not recruiting
Phase 2, Phase 3
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
Completed
Phase 3
Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery Start of enrollment: 2013 May 01
Terminated
Phase 2
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Start of enrollment: 2013 Jul 08
Completed
Phase 2
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors Start of enrollment: 2013 Sep 20
Active, not recruiting
Phase 2
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
Active, not recruiting
Phase 2
Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions Start of enrollment: 2012 Apr 27
Completed
Phase 1
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Start of enrollment: 2013 Aug 01
Active, not recruiting
Not Applicable
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Active, not recruiting
Phase 3
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer Start of enrollment: 2014 Jan 22
Active, not recruiting
Phase 2
Chemoimmunotherapy and Radiation in Pancreatic Cancer Start of enrollment: 2013 Jul 01
Completed
Phase 1
Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer Start of enrollment: 2013 Jul 01
Completed
Phase 2
Phase I Study of Safety and Immunogenicity of ADU-623 Start of enrollment: 2014 Jan 08
Completed
Phase 1
A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer Start of enrollment: 2014 Feb 28
Completed
Phase 1
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Start of enrollment: 2014 May 19
Active, not recruiting
Phase 3
A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast Cancer Start of enrollment: 2013 Dec 31
Completed
Phase 1
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Start of enrollment: 2014 Feb 01
Completed
Phase 2
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2014 Feb 20
Active, not recruiting
Phase 3
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04
Active, not recruiting
Phase 3
Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma Start of enrollment: 2014 May 08
Completed
Phase 1
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer Start of enrollment: 2014 May 01
Terminated
Phase 3
α-TEA in Advanced Cancer Start of enrollment: 2014 Aug 04
Completed
Phase 1
Pilot Study of DRibble Vaccine for Prostate Cancer Patients Start of enrollment: 2014 Oct 24
Completed
Phase 1
Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer Start of enrollment: 2017 May 26
Completed
Phase 2
Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients Start of enrollment: 2019 Apr 03
Active, not recruiting
Phase 2
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer Start of enrollment: 2019 May 17
Active, not recruiting
Phase 2
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer Start of enrollment: 2020 Jun 17
Recruiting
Phase 2, Phase 3
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer Start of enrollment: 2020 Dec 01
Active, not recruiting
Phase 2
Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer Start of enrollment: 2021 Sep 10
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Comparing Mini-Cog and Blessed Orientation-Memory-Concentration test for evaluating cognition in older patients with advanced cancer.
Kaitlin Kyi, William Consagra, Eva Culakova, Lucia Berkhof, Michelle Janelsins, James Bearden 3rd, Jeffrey Berenberg, Beverly Canin, Alison Conlin, Supriya Mohile, All...> ;Journal of Geriatric Oncology. 2024 Apr 13
Sunitinib in Patients With Breast Cancer WithorAmplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Calfa, C., Rothe, M., Mangat, P., Garrett-Mayer, E., Ahn, E., Burness, M., Gogineni, K., Rohatgi, N., Al Baghdadi, T., Conlin, A., Gaba, A., Hamid, O., Krishnamurthy, ...> ;JCO Precision Oncology. 2024 Feb 1
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.
David B Page, Joanna Pucilowska, Brie Chun, Isaac Kim, Katherine Sanchez, Nicole Moxon, Staci Mellinger, Yaping Wu, Yoshinobu Koguchi, Valerie Conrad, William L Redmon...> ;NPJ Breast Cancer. 2023 Jun 21
8 citations
Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer.
Brie Chun, Joanna Pucilowska, ShuChing Chang, Isaac Kim, Benjamin Nikitin, Yoshinobu Koguchi, William L Redmond, Brady Bernard, Venkatesh Rajamanickam, Nathan Polaske,...> ;Journal for Immunotherapy of Cancer. 2022 Jan 1
4 citations
A randomized trial of fulvestrant, everolimus and anastrozole for the front-line treatment of patients with advanced hormone receptor-positive breast cancer, SWOG S1222.
Halle C. F. Moore, William E. Barlow, George Somlo, Julie R. Gralow, Anne F. Schott, Daniel F. Hayes, Peter Kuhn, James W. Hicks, Lisa Welter, Philip A. Dy, Christina ...> ;Clinical Cancer Research. 2021 Nov 29
20 citations
Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide...
Elizabeth A. Salerno, Eva Culakova, Amber S. Kleckner, Charles E. Heckler, Po-Ju Lin, Charles E. Matthews, Alison Conlin, Lora Weiselberg, Jerry W. Mitchell, Karen M. ...> ;Journal of Clinical Oncology. 2021 Aug 18
56 citations
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE.
Eleftherios P. Mamounas, Michael Untch, Max S. Mano, C.-S. Huang, Charles E. Geyer, G. von Minckwitz, Norman Wolmark, Xavier Pivot, S. Kuemmel, Michael P. DiGiovanna, ...> ;Annals of Oncology. 2021 Aug 1
14 citations
The longitudinal relationship between immune cell profiles and frailty in patients with breast cancer receiving chemotherapy.
Nikesha Gilmore, Supriya G. Mohile, Lianlian Lei, Eva Culakova, Mostafa R. Mohamed, Allison Magnuson, Kah Poh Loh, Ronald J. Maggiore, Elizabeth Belcher, Alison Conlin...> ;Breast Cancer Research. 2021 Feb 5
6 citations
Caregiver-oncologist prognostic concordance, caregiver mastery, and caregiver psychological health and quality of life
Kah Poh Loh, Mostafa R. Mohamed, Sindhuja Kadambi, Eva Culakova, Huiwen Xu, Allison Magnuson, Marie Flannery, Paul R. Duberstein, Ronald M. Epstein, Colin McHugh, Ryan...> ;The Oncologist. 2021 Feb 1
28 citations
Associations of Uncertainty With Psychological Health and Quality of Life in Older Adults With Advanced Cancer
Haydee Cristina Verduzco-Aguirre, Dilip Sankar Babu, Supriya G. Mohile, Javier Bautista, Huiwen Xu, Eva Culakova, Beverly Canin, Yingzi Zhang, Megan Wells, Ronald M. E...> ;Journal of Pain and Symptom Management. 2021 Feb 1
8 citations
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study.
Sara M Tolaney, Muralidhar Beeram, J Thaddeus Beck, Alison Conlin, E Claire Dees, Shannon L Puhalla, Brent N Rexer, Howard A Burris, Komal Jhaveri, Teresa Helsten, Car...> ;Frontiers in Oncology. 2021 Jan 1
7 citations
Relationships of self-perceived age with geriatric assessment domains in older adults with cancer
Kah Poh Loh, Paul R. Duberstein, Jason Zittel, Lianlian Lei, Eva Culakova, Huiwen Xu, Sandy Plumb, Marie Flannery, Allison Magnuson, Javier Bautista, Marsha N. Wittink...> ;Journal of Geriatric Oncology. 2020 Jul 1
283 citations
Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER...
Nan Lin, Virginia F. Borges, Carey K. Anders, Rashmi Krishna Murthy, Elisavet Paplomata, Erika Hamilton, Sara A. Hurvitz, Sherene Loi, Alicia Okines, Vandana G. Abrams...> ;Journal of Clinical Oncology. 2020 May 29
6 citations
A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast Cancer.
David B. Page, Joanna Pucilowska, Katherine Sanchez, Valerie Conrad, Alison Conlin, Anupama K. Acheson, Kelly Shea Perlewitz, James H. Imatani, Shaghayegh Aliabadi-Wah...> ;Clinical Cancer Research. 2020 Apr 1
40 citations
Willingness to bear adversity and beliefs about the curability of advanced cancer in older adults.
Kah Poh Loh, Supriya G. Mohile, Ronald M. Epstein, Colin McHugh, Marie Flannery, Eva Culakova, Lianlian Lei, Megan Wells, Nikesha Gilmore, Dilip Sankar Babu, Mary I. W...> ;Cancer. 2019 Jul 15
50 citations
Beliefs About Advanced Cancer Curability in Older Patients, Their Caregivers, and Oncologists.
Kah Poh Loh, Supriya G. Mohile, Jennifer L. Lund, Ronald M. Epstein, Lianlian Lei, Eva Culakova, Colin McHugh, Megan Wells, Nikesha Gilmore, Mostafa R. Mohamed, Charle...> ;The Oncologist. 2019 Jun 1
31 citations
Effects of a Home-based Exercise Program on Anxiety and Mood Disturbances in Older Adults with Cancer Receiving Chemotherapy.
Kah Poh Loh, Ian R. Kleckner, Po-Ju Lin, Supriya G. Mohile, Beverly Canin, Marie Flannery, Chunkit Fung, Richard F. Dunne, Javier Bautista, Eva Culakova, Amber S. Klec...> ;Journal of the American Geriatrics Society. 2019 May 1
30 citations
Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial.
Ian R. Kleckner, Charles Kamen, Calvin L. Cole, Chunkit Fung, Charles E. Heckler, Joseph J. Guido, Eva Culakova, Adedayo A. Onitilo, Alison Conlin, J. Philip Kuebler, ...> ;Supportive Care in Cancer. 2019 Apr 2
1294 citations
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Gunter von Minckwitz, Chiun Sheng Huang, Max S. Mano, Sibylle Loibl, Eleftherios P. Mamounas, Michael Untch, Norman Wolmark, P Rastogi, Andreas Schneeweiss, Andrés Red...> ;The New England Journal of Medicine. 2019 Feb 14
91 citations
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.
Virginia F. Borges, Cristiano Ferrario, Nathalie Aucoin, Carla I. Falkson, Qamar Khan, Ian E. Krop, Stephen Welch, Alison Conlin, Jorge Chaves, Philippe L. Bedard, Mar...> ;JAMA Oncology. 2018 Sep 1
115 citations
Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1...
Rashmi Krishna Murthy, Virginia F. Borges, Alison Conlin, Jorge Chaves, Marc C. Chamberlain, Todd Gray, Alex Vo, Erika Hamilton> ;The Lancet. Oncology. 2018 May 24
364 citations
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3...
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;The Lancet. Oncology. 2017 Dec 1
218 citations
Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longi...
Michelle C. Janelsins, Charles E. Heckler, Luke J. Peppone, Charles Kamen, Karen M. Mustian, Supriya G. Mohile, Allison Magnuson, Ian R. Kleckner, Joseph J. Guido, Kel...> ;Journal of Clinical Oncology. 2017 Feb 10
6 citations
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as A...
John W. Smith, Marc Buyse, Priya Rastogi, Charles E. Geyer, Samuel A. Jacobs, Erica Patocskai, André Robidoux, Alison Conlin, Bilal Ansari, George P. Keogh, Philip J. ...> ;Clinical Breast Cancer. 2017 Feb 1
43 citations
What does Medicaid expansion mean for cancer screening and prevention? Results from a randomized trial on the impacts of acquiring Medicaid coverage.
Bill J. Wright, Alison Conlin, Heidi Allen, Jennifer Tsui, Matthew J. Carlson, Hsin Fang Li> ;Cancer. 2016 Mar 1
Join now to see all

Hospital Affiliations

Providence Milwaukie HospitalPortland, Oregon
Providence Newberg Medical CenterNewberg, Oregon
Providence Portland Medical CenterPortland, Oregon
Providence St. Vincent Medical CenterPortland, Oregon
Providence Hood River Memorial HospitalHood River, Oregon
Providence Seaside HospitalSeaside, Oregon
Providence Willamette Falls Medical CenterOregon City, Oregon